Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00964691Phase 4Terminated
Phase 4, randomised, open-label trial of sulfadoxine and pyrimethamine in malaria, sponsored by Ministry of Health and Medical Services. Primary endpoint: Placental malaria among primigravidae at time of delivery. Started Aug 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00964691.